$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921012313 Filed on May 14, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$2.925M	$1.811M
YoY Change	61.46%	-5.46%
Cost Of Revenue	$1.122M	$527.3K
YoY Change	112.88%	-14.78%
Gross Profit	$1.802M	$1.284M
YoY Change	40.35%	-1.01%
Gross Profit Margin	61.62%	70.89%
Selling, General & Admin	$2.749M	$2.748M
YoY Change	0.05%	30.3%
% of Gross Profit	152.54%	214.0%
Research & Development	$16.44K	$107.5K
YoY Change	-84.7%	1593.67%
% of Gross Profit	0.91%	8.37%
Depreciation & Amortization	$20.92K	$37.22K
YoY Change	-43.78%	42.9%
% of Gross Profit	1.16%	2.9%
Operating Expenses	$2.787M	$2.893M
YoY Change	-3.67%	36.75%
Operating Profit	-$984.4K	-$1.609M
YoY Change	-38.81%	96.61%
Interest Expense	-$2.540K	$110.00
YoY Change	-2409.09%	-99.73%
% of Operating Profit
Other Income/Expense, Net		-$4.210K
YoY Change		85.95%
Pretax Income	-$986.9K	-$1.613M
YoY Change	-38.8%	106.98%
Income Tax	$250.00	$250.00
% Of Pretax Income
Net Earnings	-$972.9K	-$1.600M
YoY Change	-39.2%	104.43%
Net Earnings / Revenue	-33.26%	-88.34%
Basic Earnings Per Share	-$0.01	-$0.03
Diluted Earnings Per Share	-$0.01	-$0.03
COMMON SHARES
Basic Shares Outstanding	66.58M	49.73M
Diluted Shares Outstanding	66.58M	49.73M

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$16.95M	$766.0K
YoY Change	2112.94%	-72.04%
Cash & Equivalents	$16.95M	$766.0K
Short-Term Investments
Other Short-Term Assets	$688.8K	$707.0K
YoY Change	-2.57%	13.93%
Inventory	$2.021M	$1.723M
Prepaid Expenses
Receivables	$978.8K	$1.290M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$21.66M	$5.261M
YoY Change	311.68%	-28.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.07K	$29.96K
YoY Change	-9.64%	-61.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$24.15K
YoY Change	0.0%	39.15%
Total Long-Term Assets	$981.7K	$1.113M
YoY Change	-11.83%	72.03%
TOTAL ASSETS
Total Short-Term Assets	$21.66M	$5.261M
Total Long-Term Assets	$981.7K	$1.113M
Total Assets	$22.64M	$6.375M
YoY Change	255.18%	-19.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$694.0K	$1.444M
YoY Change	-51.93%	20.45%
Accrued Expenses	$1.179M	$832.3K
YoY Change	41.64%	-46.24%
Deferred Revenue
YoY Change
Short-Term Debt	$276.2K	$0.00
YoY Change
Long-Term Debt Due	$7.980K
YoY Change
Total Short-Term Liabilities	$3.039M	$5.240M
YoY Change	-42.01%	0.4%
LONG-TERM LIABILITIES
Long-Term Debt	$26.54K	$34.52K
YoY Change	-23.12%
Other Long-Term Liabilities	$538.4K	$612.0K
YoY Change	-12.03%	3744.35%
Total Long-Term Liabilities	$565.0K	$646.5K
YoY Change	-12.62%	3961.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.039M	$5.240M
Total Long-Term Liabilities	$565.0K	$646.5K
Total Liabilities	$3.604M	$5.887M
YoY Change	-38.78%	12.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.9M	-$95.12M
YoY Change	7.08%	9.61%
Common Stock	$121.9M	$96.60M
YoY Change	26.2%	6.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$19.14M	$567.8K
YoY Change
Total Liabilities & Shareholders Equity	$22.64M	$6.375M
YoY Change	255.18%	-19.93%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$972.9K	-$1.600M
YoY Change	-39.2%	104.43%
Depreciation, Depletion And Amortization	$20.92K	$37.22K
YoY Change	-43.78%	42.9%
Cash From Operating Activities	-$967.8K	-$972.1K
YoY Change	-0.44%	341.51%
INVESTING ACTIVITIES
Capital Expenditures	$5.916K	$7.138K
YoY Change	-17.12%	-11.92%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.916K	-$7.138K
YoY Change	-17.12%	-11.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.701M	228.9K
YoY Change	1516.51%	-89.71%
NET CHANGE
Cash From Operating Activities	-$967.8K	-972.1K
Cash From Investing Activities	-$5.916K	-7.138K
Cash From Financing Activities	$3.701M	228.9K
Net Change In Cash	$2.727M	-750.3K
YoY Change	-463.43%	-137.58%
FREE CASH FLOW
Cash From Operating Activities	-$967.8K	-$972.1K
Capital Expenditures	$5.916K	$7.138K
Free Cash Flow	-$973.7K	-$979.2K
YoY Change	-0.56%	328.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q1	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	382627
CY2020Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	586734
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
CY2021Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	1918925
CY2020Q1	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	460725
CY2021Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	1.57
CY2020Q1	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.50
CY2021Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2020Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2021Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
CY2020Q1	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
CY2021Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod
CY2020Q1	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod
CY2021Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
CY2020Q1	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice
CY2021Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	33238
CY2020Q1	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	102768
CY2021Q1	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	241288
CY2020Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	242589
CY2021Q1	mlss	Expenses Paid Stock ExpensesPaidStock
CY2020Q1	mlss	Expenses Paid Stock ExpensesPaidStock	25000
CY2021Q1	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2685
CY2020Q1	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2252
CY2021Q1	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1059966
CY2020Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1048614
CY2021Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-987158
CY2020Q1	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1612953
CY2021Q1	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	753197
CY2020Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	414202
CY2021Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-204107
CY2020Q1	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-76406
CY2021Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	338995
CY2020Q1	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	65171
CY2021Q1	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	612576
CY2020Q4	mlss	Lease Rightofuse Asset LeaseRightofuseAsset	632453
CY2021Q1	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	1883
CY2020Q1	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	27627
CY2021Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred
CY2020Q1	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-706071
CY2021Q1	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability
CY2020Q1	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	706071
CY2021Q1	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
CY2021Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	115000
CY2020Q1	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	186035
CY2020Q1	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock	15012
CY2021Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	3012216
CY2020Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	230362
CY2021Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	100000
CY2020Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	171046
CY2021Q1	mlss	Stock To Be Issued During Period Value Issued For Services StockToBeIssuedDuringPeriodValueIssuedForServices	40
CY2021Q1	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
CY2020Q1	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
CY2021Q1	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm
CY2020Q1	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm
CY2020	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y175D
CY2021Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y94D
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y36D
CY2020Q1	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P3Y310D
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	694044
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	482972
CY2021Q1	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	184360
CY2020Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	385138
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	978761
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1080656
CY2021Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	267300
CY2020Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1178907
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	824454
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	121848254
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	117934696
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	113507
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30715
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11352
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13253
CY2021Q1	us-gaap	Assets Assets	22641033
CY2020Q4	us-gaap	Assets Assets	19571450
CY2021Q1	us-gaap	Assets Current AssetsCurrent	21659337
CY2020Q4	us-gaap	Assets Current AssetsCurrent	18554869
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16950710
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14223917
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14223917
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1516272
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16950710
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	765975
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2726793
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-750297
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.49
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.14
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6369396
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4450471
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	613446
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66591883
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	64171435
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66558550
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	64138102
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	66591
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	64171
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	178000
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1122413
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	527250
CY2020Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2440878
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2375760
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2408151
CY2020Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2466533
CY2021Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	65965
CY2020Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	11995
CY2021Q1	us-gaap	Depreciation Depreciation	9572
CY2020Q1	us-gaap	Depreciation Depreciation	23966
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20924
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37219
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20924
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	37219
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2021Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	34521
CY2020Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	36403
CY2021Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7977
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7796
CY2021Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	26544
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-984373
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1608606
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	612016
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	630012
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	73596
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	28607
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1883
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1442
CY2021Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y292D
CY2020Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y292D
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-317897
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-329249
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	317896
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	329249
CY2021Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1301
CY2020Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2021Q1	us-gaap	Gross Profit GrossProfit	1802294
CY2020Q1	us-gaap	Gross Profit GrossProfit	1284136
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-986908
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1612703
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1301
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250
CY2021Q1	us-gaap	Inventory Net InventoryNet	2020549
CY2020Q4	us-gaap	Inventory Net InventoryNet	2420179
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-200778
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	30567
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	211072
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	64317
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-101895
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-421127
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	267300
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	339518
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	215437
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-399630
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	102316
CY2021Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables
CY2020Q1	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11755
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	272905
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	165032
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2535
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4097
CY2021Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	450000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	453000
CY2021Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	337678
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	331711
CY2021Q1	us-gaap	Liabilities Liabilities	3603944
CY2020Q4	us-gaap	Liabilities Liabilities	3464482
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22641033
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19571450
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3038979
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2877894
CY2021Q1	us-gaap	Minority Interest MinorityInterest	-107414
CY2020Q4	us-gaap	Minority Interest MinorityInterest	-94426
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3700523
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	228920
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5916
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7138
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-967814
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-972079
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-972869
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1600215
CY2021Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12988
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12738
CY2021Q1	us-gaap	Notes Payable Current NotesPayableCurrent	276180
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	276180
CY2021Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	2786667
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	2892742
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	72031
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	538421
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	557981
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	31303
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	17264
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	579990
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597770
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5916
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7138
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	688820
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	415915
CY2021Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;">Certain reclassification has been made to the <div style="display: inline; font-style: italic; font: inherit;">2020</div> unaudited condensed consolidated financial statements to conform to the <div style="display: inline; font-style: italic; font: inherit;">2021</div> unaudited condensed consolidated financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net loss or cash flows as previously reported.</div></div></div></div></div></div></div>
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	690190
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3012216
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	230362
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-985857
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1612953
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27074
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30729
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16444
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	107480
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	30715
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101858826
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100885957
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2924707
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1811386
CY2021Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	506400
CY2020Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2749299
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2748043
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	113507
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	15000000
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	13100000
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	18
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	690190
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	19144503
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	16201394
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	16106968
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	19037089
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487829
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2784117
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6381930
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012
CY2020Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	460085
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	66578435
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49730252
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	66578435
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49730252

Files In Submission

Name	View Source	Status
0001437749-21-012313-index-headers.html	Edgar Link	pending
0001437749-21-012313-index.html	Edgar Link	pending
0001437749-21-012313.txt	Edgar Link	pending
0001437749-21-012313-xbrl.zip	Edgar Link	pending
ex_241459.htm	Edgar Link	pending
ex_241461.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20210331.xml	Edgar Link	completed
mlss-20210331.xsd	Edgar Link	pending
mlss-20210331_cal.xml	Edgar Link	unprocessable
mlss-20210331_def.xml	Edgar Link	unprocessable
mlss-20210331_lab.xml	Edgar Link	unprocessable
mlss-20210331_pre.xml	Edgar Link	unprocessable
mlss20210331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2021 Q1 Form 10-Q Financial Statement

#000143774921012313 Filed on May 14, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2021 Q1 Form 10-Q Financial Statement

#000143774921012313 Filed on May 14, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss